Drug Profile
Anti-hepatitis B ribozyme - Ribozyme Pharmaceuticals
Alternative Names: HepBzymeLatest Information Update: 08 Jan 2008
Price :
$50
*
At a glance
- Originator Sirna Therapeutics
- Class
- Mechanism of Action RNA inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hepatitis B